MedPath

Difference between drugs in critically ill patient with enteral feed intolerance.

Not Applicable
Conditions
Health Condition 1: R00-R99- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Registration Number
CTRI/2024/02/062858
Lead Sponsor
Eras Lucknow medical college and hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Critically ill patients admitted in ICU who had enteral feed intolerence.

Patients of either sex

Patients of age group 18-75 year

Exclusion Criteria

Patients with allergy to study drugs.

Treatment with any prokinetics drugs 24 h before participating in the study.

Hemodynamic instability or presence of cardarrhythmia or prolonged QT interval .

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
PRIMARY OBJECTIVES: <br/ ><br>The rate of successful feeding at 48 hours after randomization. <br/ ><br>Timepoint: 48 hours.
Secondary Outcome Measures
NameTimeMethod
Icu length of stay <br/ ><br>Hospital length of stay <br/ ><br>Timepoint: Icu length of stay <br/ ><br>Hospital length of stay
© Copyright 2025. All Rights Reserved by MedPath